On a June afternoon in 2019, two inspectors from the Food and Drug Administration visited a warehouse in San Francisco. The uniformed women pulled out of a briefcase a printout of a Fortune story headlined: “Startups disrupted breast pumps. Is infant formula next?” On that piece of paper, they had highlighted every place the words […]